PPT-Updated Guidelines for Cervical Cancer Screening and Prevention

Management of Abnormal Results Kathy A King MD Assistant Professor of OBGYN Medical Director PPWI Medical College of Wisconsin May 6 2016 Objectives Overview of cervical cancer and oncogenic HPV. Interactions and Interventions. Jean R. Anderson, M.D.. Jhpiego, an affiliate of Johns Hopkins University. The Johns Hopkins University School of Medicine. Cervical Cancer. Latest data on cervical cancer incidence and mortality (GLOBOCAN 2008, IARC*):. Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . S.A. . Nadji. , PhD. Associate professor of virology. Head, Virology research center, . nritld. , . sbmu. . Ranking of the 7 most common HPV types . Type distribution for nearly 30’000 HPV related cancers from 38 countries participants in ICO surveys 2005 - 2014. Annual CPCRN Meeting, Chicago. Tuesday, May 24. th. . Lead: Karen Glanz, PhD, MPH. Participating Sites: . UPenn. , UNC, . UWash. , CDC, NCI. This presentation was supported by Cooperative Agreement Number U48 DP005053 from the Centers for Disease Control and Prevention. The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. . Judith.rosen.1.ctr@us.af.mil. MHSPHP: Patients and Metrics. 2. Patient Detail View. Overview. Breast Cancer Screening. Clinical recommendations versus HEDIS. Metric versus Lists. Cervical Cancer Screening. 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. Objectives . 1. What is cervical cancer?. 2. Who gets cervical cancer?. 3. Can it be prevented?. 4. What treatment is available?. . Quiz time!. Which viral infection is the most common cause of cervical cancer?. CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Cancer. (Resource-Stratified). SH-. Shiekhhasani. GYN.Oncologist. TEHRAN UNIVERSITY. Cervical cancer is the . fourth most common cancer . and . fourth leading cause of cancer-related mortality. in women worldwide.. Selemawit. Ghebrendrias. 1. , Sarah Pfeil. 1. , Sheila K. Mody. 1. , Bonnie Crouthamel. 1. , Morgen Chalmiers. 1. , . Gennifer. Kully. 1. 1. Division Of Family Planning, Department Of Obstetrics, Gynecology, And Reproductive Sciences, University Of California, San Diego. Host. – . Mandeep Singh . Ahluwalia. Speakers. – Mandeep Ahluwalia, Karen Burgess, Bikram Raychaudhuri, Jane Lodge and Amy Dissanayake. . . . The webinar will commence at 1pm. Please remember to turn off your mics and cameras. . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3. 1. Cancer Screening Update IDCA MeetingSeptember 20, 20132. OverviewOntario’s Cancer Screening ProgramsOntario Breast Screening Program (OBSP)CR Mammography Technology Transition Project23. Ontario’s Cancer Screening ProgramsOntario Breast...